Investors are less than enthusiastic about the current market, what will it take to get them back?
Inflation data has prompted speculation that the Fed could raise rates in the summer.
An analysis by Bank of America/Merrill Lynch shows that investors are turning a cold shoulder to stocks.
The biggest retail names are down after dismal earnings, but options traders are betting on a few choice companies.
Is the drop in yields a good or a bad indicator for stocks? Erin Gibbs of S&P Investment Advisory and Gina Sanchez of Chantico Global discuss with Dominic Chu.
What’s behind the Dow transportation lag? Erin Gibbs of S&P Investment Advisory and Gina Sanchez of Chantico Global discuss with Dominic Chu.
Former OMB Director David Stockman says that a Trump presidency will scare the hell out of the markets, but that's what it needs.
Former OMB Director David Stockman says that it doesn't matter if Hillary Clinton or Donald Trump become president - they won't be able to stop a recession.
Former OMB Director David Stockman says that the markets are on the verge of a massive metldown.
How will the presidential race impact stocks? Ernie Cecilia of Bryn Mawr Trust and Boris Schlossberg of BK Asset Management discuss with Dominic Chu.
The “minimum volatility” ETF is attracting billions and outperforming the S&P 500. Ernie Cecilia of Bryn Mawr Trust and Boris Schlossberg of BK Asset Management discuss with Dominic Chu.
The bonds of countries like Mexico and Brazil look very attractive right now, according to BlackRock’s Pablo Goldberg. He discusses with Brian Sullivan.
Amazon and Facebook hit record highs Wednesday as Macy’s and Disney plunged. Nick Colas of Convergex and Max Wolff of Manhattan Venture Partners discuss the rise of the “disruptive” behemoths.
Mark Tepper of Strategic Wealth Partners and Dennis Davitt of Harvest Volatility Management discuss market breadth with Brian Sullivan.
Will high-dividend stocks continue to do well? Mark Tepper of Strategic Wealth Partners and Dennis Davitt of Harvest Volatility Management discuss with Brian Sullivan.
Evercore ISI technical analyst Rich Ross breaks down why specialty pharma company Allergan is set to rally.
It’s been a frustrating couple of months for investors as stocks continue to churn in a narrow range. But according to one trader the S&P 500 could soon make a run back at its 2016 high—and he has a clever strategy to double your money on the way up.
The big names in the defense industry have performed well this year. Ari Wald of Oppenheimer and Eddy Elfenbein of “Crossing Wall Street” discuss with Brian Sullivan.
With Tesla shares falling into reverse, Ari Wald of Oppenheimer and Eddy Elfenbein of “Crossing Wall Street” discuss the stock’s future with Brian Sullivan.
Analysts say banks' FICC desk's poor performance has hit a low point and will bounce back.